.@EvgenPharma reported full-year results to 31 March that were c.£0.3m better than expected, with an adjusted net loss of £2.7m that resulted in year-end cash of £4.1m. Read full report here by @finnCap #shares #stocks
https://t.co/uoiPKt6X2C https://t.co/Ll0PWuBT5w